1. Home
  2. NATL vs TVTX Comparison

NATL vs TVTX Comparison

Compare NATL & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NCR Atleos Corporation

NATL

NCR Atleos Corporation

HOLD

Current Price

$38.74

Market Cap

2.7B

Sector

N/A

ML Signal

HOLD

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

HOLD

Current Price

$40.17

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NATL
TVTX
Founded
2023
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
3.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NATL
TVTX
Price
$38.74
$40.17
Analyst Decision
Buy
Strong Buy
Analyst Count
4
15
Target Price
$42.75
$37.21
AVG Volume (30 Days)
421.2K
1.7M
Earning Date
11-05-2025
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.74
N/A
Revenue
$4,322,000,000.00
$435,826,000.00
Revenue This Year
$2.83
$120.02
Revenue Next Year
$3.96
$37.00
P/E Ratio
$22.18
N/A
Revenue Growth
0.63
114.22
52 Week Low
$22.30
$12.91
52 Week High
$42.23
$42.13

Technical Indicators

Market Signals
Indicator
NATL
TVTX
Relative Strength Index (RSI) 59.43 68.40
Support Level $38.20 $33.49
Resistance Level $39.49 $42.13
Average True Range (ATR) 0.82 1.92
MACD 0.05 0.40
Stochastic Oscillator 77.15 77.66

Price Performance

Historical Comparison
NATL
TVTX

About NATL NCR Atleos Corporation

NCR Atleos Corp is financial technology company providing self-directed banking solutions to a customer base including financial institutions, merchants, manufacturers, retailers and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware and its proprietary Allpoint network. Atleos manage its operations in the following segments which includes Self-Service Banking, Network, and Telecommunications abd Technology.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

Share on Social Networks: